Skip to Content

ERASE IT KIT

Dosage form: kit
Ingredients: TITANIUM DIOXIDE 11g in 100mL, ZINC OXIDE 4g in 100mL; SALICYLIC ACID 2g in 100mL;
Labeler: mybody
NDC Code: 49520-501

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

ACTIVE INGREDIENT

SALICYLIC ACID 2%

PURPOSE

ACNE TREATMENT

USE FOR TREATMENT OF ACNE

WARNINGS

FOR EXTERNAL USE ONLY

DO NOT USE * IF YOU HAVE VERY SENSITIVE SKIN OR ARE SENSITIVE TO SALICYLIC ACID.

ASK A DOCTOR OR PHARMACIST BEFORE USE IF *PREGNANT OR LACTATING. YOU ARE USING OTHER TOPICAL ACNE MEDICATIONS AT THE SAME TIME OR IMMEDIATELY FOLLOWING USE OF THIS PRODUCT. THIS MAY INCREASE DRYNESS OR IRRITATION OF THE SKIN. IF THIS OCCURS, ONLY ONE MEDICATION SHOULD BE USED UNLESS DIRECTED BY A DOCTOR.

WHEN USING THIS PRODUCT * AVOID CONTACT WITH EYES. IF CONTACT OCCURS, FLUSH THOROUGHLY WITH WATER. * KEEP AWAY FROM LIPS AND MOUTH.

KEEP OUT OF REACH OF CHILDREN. IF SWALLOWED, GET MEDICAL HELP OR CONTACT A POISON CONTROL CENTER RIGHT AWAY.

DIRECTIONS

* USE AM/PM OR AS DIRECTED BY A DOCTOR. APPLY A NICKEL-SIZE AMOUNT TO WET HANDS. RUB TOGETHER. GENTLY MASSAGE ONTO FACE AND NECK WITH CIRCULAR MOTIONS. LEAVE ON 1-2 MINUTES THEN RINSE WELL.

OTHER INFORMATION

* AVOID STORAGE AT EXTREME TEMPERATURES (BELOW 40°F AND ABOVE 100°F).

INACTIVE INGREDIENTS: WATER, DISODIUM LAURETH SULFOSUCCINATE, SODIUM COCOYL ISETHIONATE, SODIUM LAUROAMPHOACETATE, GLYCERIN, SODIUM METHYL COCOYL TAURATE, METHYLISOTHIAZOLINONE, COCAMIDOPROPYL BETAINE, BISABOLOL, ZINGIBER OFFICINALE (GINGER) ROOT EXTRACT, OAT (AVENA SATIVA) KERNEL EXTRACT, DISODIUM EDTA, BETA GLUCAN, EUCALYPTUS GLOBULUS OIL, XANTHAN GUM, MENTHOL, MYRISTOYL TETRAPEPTIDE-13, ACETYL CARBOXYMETHYL COCOYL GLYCINE, PHENOXYETHANOL, CAPRYLYL GLYCOL.

QUESTIONS OR COMMENTS?

CALL 877.423.1314 * WWW.LOVEMYBODY.COM

Established Pharmacological Class
SubstancePharmacological Class
BREAK FREELotions, Oils, Powders, and Creams
ERASE IT KIT 
salicylic acid, titanium dioxide, zinc oxide kit
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:49520-501
Packaging
#Item CodePackage Description
1NDC:49520-501-641 KIT in 1 KIT
Quantity of Parts
Part #Package QuantityTotal Product Quantity
Part 1
Part 2
Part 3
Part 4
Part 1 of 4
PROTECT AND SERVE  TINTED SUN SHIELD SPF 30
titanium dioxide and zinc oxide lotion
Product Information
Item Code (Source)NDC:49520-301
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TITANIUM DIOXIDE (TITANIUM DIOXIDE) TITANIUM DIOXIDE11 g  in 100 mL
ZINC OXIDE (ZINC OXIDE) ZINC OXIDE4 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
CYCLOMETHICONE 5 
CYCLOMETHICONE 
DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE) 
METHYL METHACRYLATE/GLYCOL DIMETHACRYLATE CROSSPOLYMER 
SORBITAN ISOSTEARATE 
TRIBEHENIN 
CALCIUM BEHENATE 
MELANIN SYNTHETIC (TYROSINE, PEROXIDE) 
DIMETHICONOL (41 MPA.S) 
ALUMINUM OXIDE 
PEG-10 DIMETHICONE (600 CST) 
METHICONE (20 CST) 
FERRIC OXIDE RED 
CHOLECALCIFEROL 
LYCOPENE 
GLYCERIN 
SUCROSE PALMITATE 
LECITHIN, SOYBEAN 
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart35209/23/2012
Part 2 of 4
TAKE CONTROL CALMING  CLEANSER
salicylic acid gel
Product Information
Item Code (Source)NDC:49520-104
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (SALICYLIC ACID) SALICYLIC ACID2 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
WATER 
DISODIUM LAURETH SULFOSUCCINATE 
SODIUM COCOYL ISETHIONATE 
SODIUM LAUROAMPHOACETATE 
GLYCERIN 
SODIUM METHYL COCOYL TAURATE 
METHYLISOTHIAZOLINONE 
COCAMIDOPROPYL BETAINE 
.ALPHA.-BISABOLOL, (+/-)- 
GINGER 
OAT 
EDETATE DISODIUM 
CURDLAN 
EUCALYPTUS OIL 
XANTHAN GUM 
MENTHOL 
MYRISTOYL PENTAPEPTIDE-4 
ACETYL CARBOXYMETHYL COCOYL GLYCINE 
PHENOXYETHANOL 
CAPRYLYL GLYCOL 
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart333D09/27/2012
Part 3 of 4
LET ME CLARIFY 
salicylic acid gel
Product Information
Item Code (Source)NDC:49520-103
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (SALICYLIC ACID) SALICYLIC ACID2 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
WATER 
1,3-BUTYLENE GLYCOL 
GLYCOLIC ACID 
POLYQUATERNIUM-10 (400 CPS AT 2%) 
EUCALYPTUS GLOBULUS LEAF 
GLYCYRRHIZA GLABRA 
ACETYL CARBOXYMETHYL COCOYL GLYCINE 
MYRISTOYL TETRAPEPTIDE-4 
HYDROXYPHENYL PROPAMIDOBENZOIC ACID 
PENTYLENE GLYCOL 
POTASSIUM HYDROXIDE 
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart333D09/24/2012
Part 4 of 4
BREAK FREE 
Product Information
Item Code (Source)49520-901
Ingredients
Ingredient NameQuantity
WATER 
PENTYLENE GLYCOL 
COCO-GLYCERIDES 
LAURYL LAURATE 
MYRISTOYL PENTAPEPTIDE-4 
HYDROXYPHENYL PROPAMIDOBENZOIC ACID 
4-TERT-BUTYLCYCLOHEXANOL 
SODIUM HYDROXIDE 
EUCALYPTUS GLOBULUS LEAF 
LECITHIN, SOYBEAN 
POLYGLYCERIN-10 
CARBOMER COPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED) 
ACETYL CARBOXYMETHYL COCOYL GLYCINE 
LAURYL METHACRYLATE/GLYCOL DIMETHACRYLATE CROSSPOLYMER 
TROMETHAMINE 
BUTYLENE GLYCOL 
CAPRYLYL GLYCOL 
PHENOXYETHANOL 
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Cosmetic09/24/2012
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart333D05/10/2014
Labeler - mybody (004460532)

Revised: 06/2014
 
mybody

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide